Mirai Bio and Thermo Fisher partner to integrate AI-driven design with CGMP manufacturing, aiming to streamline development ...

Fintel reports that on May 19, 2025, D. Boral Capital downgraded their outlook for Imunon (NasdaqCM:IMNN) from Buy to Hold.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Innovative delivery techniques, including high-tech nanoparticles and electroporationdevices, may convey more gene therapies ...

A study has found that an ancient protein motif that binds to nucleic acids is functionally "ambidextrous." This means that ...

The prospectus describes RBD4059, one of Ribo Life's core candidate products, as the world's first and most advanced siRNA ...

Applied DNA Sciences, Inc. (NASDAQ:APDN) (”Applied DNA” or the “Company”), a leader in polymerase chain reaction (PCR)-based technologies, will release its financial results for the second quarter of ...

About Creyon Bio, Inc. Creyon Bio is a nucleic acid drug development company whose ... The company is working to develop world-class, tissue-specific, RNA-targeted oligo therapies by combining ...

Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform ...